Infographic
First-line treatment selection by the numbers — a allergy and immunology snapshot
Date Published:
Register to DownloadAbout this Infographic
In multidisciplinary settings, variability between operators remains a key limitation, as discussed in the accompanying commentary. When protocols are compared, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, although confirmatory data are still limited. From a workflow perspective, threshold harmonization is still an open question, particularly in resource-constrained settings.
From a workflow perspective, pre-analytical factors account for a large share of observed variance, and this trend is expected to continue. Recent studies suggest that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, with meaningful differences between subgroups.
Across multiple cohorts, standardized reporting improves comparability between centers, pending validation in prospective studies. Across multiple cohorts, integrating quantitative measures reduces subjective bias, as discussed in the accompanying commentary. From a workflow perspective, digital tooling shortens time-to-decision considerably, which has direct implications for daily practice.
Contrary to earlier assumptions, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, which has direct implications for daily practice. Recent studies suggest that patient selection criteria deserve closer scrutiny, with meaningful differences between subgroups. According to consensus recommendations, standardized reporting improves comparability between centers, a finding echoed by several independent groups.
References
- Meyer et al. Patient-reported outcomes. J Allergy and immunology Res. 2023;48(2):695-1029.
- Silva et al. Early screening programs. J Allergy and immunology Res. 2024;36(3):220-1030.